Skip to main content
CLGN
NASDAQ Industrial Applications And Services

Loewenbaum Group Reveals 18.6% CollPlant Stake Following $2.6M Private Placement

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$0.305
Mkt Cap
$5.767M
52W Low
$0.271
52W High
$3.232
52W Position info
13% above low
Off High info
91% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

CLGN is trading near its 52-week low of $0.271 (13% above the low).

Summary

The Loewenbaum family group disclosed an 18.6% stake in CollPlant after acquiring shares and warrants in the recent $2.6 million private placement, with warrants priced above the current stock price.


Key Events · Ownership and Investor Activity · CLGN

  • Loewenbaum Group Takes 18.6% Stake

    Beneficial ownership now stands at 3,518,237 ordinary shares for the Loewenbaum family group—comprising trusts and individuals—which translates to 18.6% of CollPlant's outstanding shares.

  • Acquired Shares and Warrants in Private Placement

    As part of the $2.6 million private placement, The Loewenbaum 1992 Trust purchased 1,764,706 ordinary shares, Series A Warrants for 1,764,706 shares, and Series B Warrants for 3,529,412 shares.

  • Warrants Priced Above Market

    With an exercise price of $0.34 per share, the warrants are set above the current stock price of $0.305, indicating confidence in the company's valuation.

  • Warrant Exercisability Contingent on Shareholder Vote

    Exercisability of the warrants hinges on shareholder approval, which is expected at the July 29, 2026 extraordinary general meeting where an increase in authorized shares will be voted on.


Analysis · CLGN · Industrial Applications And Services

After participating in the recent $2.6 million private placement, the Loewenbaum family group—led by George Walter and Lilian S. Loewenbaum—now controls 18.6% of CollPlant. The filing details the group's acquisition of 1.76 million shares and warrants with a $0.34 exercise price, which sits above the current $0.305 stock price, signaling confidence despite the company's severe cash crunch and an upcoming shareholder vote to authorize more shares. Because the warrants are contingent on shareholder approval expected July 29, a near-term catalyst is in play. While this concentrated insider buying provides a vote of confidence, the group's control position and the dilutive warrant overhang remain key risks.

At the time of this filing, CLGN was trading at $0.31 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $5.8M. The 52-week trading range was $0.27 to $3.23. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CLGN - Latest Insights

CLGN
Jul 09, 2026, 4:25 PM EDT
Filing Type: F-3
Importance Score:
8
Price at Filing: $0.3587
Real-time Price: $0.3189 info
Change: -$0.0398 (-11%) info
Market Cap: $6.03M info
CLGN
Jul 07, 2026, 4:05 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.360
Real-time Price: $0.3189 info
Change: -$0.0411 (-11%) info
Market Cap: $6.03M info
CLGN
Jul 01, 2026, 8:36 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.343
Real-time Price: $0.3189 info
Change: -$0.0241 (-7%) info
Market Cap: $6.03M info
CLGN
Jun 30, 2026, 8:00 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $0.3593
Real-time Price: $0.3189 info
Change: -$0.0404 (-11%) info
Market Cap: $6.03M info
CLGN
May 29, 2026, 7:11 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.4281
Real-time Price: $0.3189 info
Change: -$0.1092 (-26%) info
Market Cap: $6.03M info